AIM: Increased intracranial pressure following trauma and subsequent possible development of brain death are important factors for morbidity and mortality due to ischemic changes. We aimed to establish the role of ischemic modifi ed albumin (IMA) in the early diagnosis of the process, starting with increased intracranial pressure and ending with brain death. MATERIALS AND METHODS: Eighteen Wistar-Albino rats were divided into three groups; control (CG, n = 6), increased intracranial pressure (ICPG, n = 6), and brain death (BDG, n = 6). Intracranial pressure elevation and brain death were constituted with the infl ation of a balloon of a Fogarty catheter in the epidural space. In all three groups, blood samples were drawn before the procedure, and at minutes 150 and 240 for IMA and malondialdehyde (MDA) analysis. RESULTS: Serum IMA levels at 150 and 240 minutes were higher in ICPG than in CG (p < 0.05). IMA levels were similar in ICPG and BDG. Serum MDA levels at 150 and 240 minutes increased in ICPG and BDG groups compared to CG (p < 0.05). MDA levels were similar in ICP and BD groups. CONCLUSION: IMA should be considered as a biochemical parameter in the process starting from increased intracranial pressure elevation and ending at brain death (Tab. 3, Fig. 5, Ref. 31) . Text in PDF www.elis.sk. KEY WORDS: ischemic modifi ed albumin, increased intracranial pressure, brain death.
Introduction
Currently, head trauma is still an important cause of mortality and morbidity. An increased intracranial pressure (ICP), defi ned as an intracranial pressure of higher than 20 mm Hg, is an important problem of the neurological intensive care practice. Increased ICP may create acute or chronic pathological processes related to its intracranial mass effect. Intracranial hematomas, neoplasms, cerebral edema, traumatic brain injury, stroke, obstructive hydrocephalus, venous sinus obstruction, encephalitis, meningitis, and hypoxic ischemic changes may cause an increase in the ICP (1) (2) (3) .
As a result of elevated ICP, some conditions such as low cerebral perfusion pressure and cerebral herniation may occur. In cases, such as intracerebral hemorrhage, ischemia may develop in the compressed area around the hematoma with the increase in the ICP due to a mass effect of the hematoma or progressing edema. Following traumatic brain injury, cerebral ischemia may ensue as a result of the pathophysiological changes in cerebral blood fl ow and brain metabolism (1) (2) (3) (4) .
Human serum albumin with a molecular weight of 66,500 Dalton is composed of 585 amino acids. The amino terminal (Nterminal) of the human serum albumin molecule is the binding place for transition metals such as cobalt, copper, and nickel. The formation of free radicals following ischemia/reperfusion causes changes in the amino-terminal and results in a decreased binding capacity for those metals when albumin passes into the ischemic tissue. This changed modifi ed version of albumin is called ischemic modifi ed albumin (IMA). It is a modifi ed protein and its cobalt binding capacity is decreased under ischemic conditions (5) (6) (7) (8) .
Recently IMA, as a biochemical marker, has been studied extensively in ischemic tissues. IMA, which is considered as a possible early predictor of myocardial ischemia, may also increase in many diseases such as mesenteric thrombosis, pulmonary embolus, infection, cerebrovascular event, end stage renal failure, and tumors (7) .
Biochemical parameters that can be used in the early period for the diagnosis of some common pathological conditions in neurological intensive care units, such as increased ICP, cerebral herniation and brain death (BD), are limited. The current study aimed to evaluate the availability of increased IMA levels in the early diagnosis of elevated ICP, which has not been studied previously in literature, and BD that develops secondary to elevated ICP.
Materials and methods
Approval for this study was obtained from the Local Ethics Committee for Experimental Animals of Gazi University (27.03.2014/66332047-604.01.02-8653) and the study was performed at the Experimental Research Center of Gazi University. Eighteen male Wistar Albino rats weighing 250-350 g were divided into three groups for the study; control group (CG, n = 6), increased intracranial pressure group (ICPG, n = 6), and brain death group (BDG, n = 6). All rats were kept in standard conditions (such as 21 ± 2 °C, appropriate humidity, 12-24-hour day/ night cycles and adequate fl uid and food support).
Preparation period
Rats were anesthetized using intraperitoneal ketamine hydrochloride 60 mg/kg (Ketalar; Eczacibasi, Turkey) and xylazine 12 mg/kg (Rompun; Bayer, Turkey). Ketamine hydrochloride was administered as bolus doses when necessary during maintenance. All rats were followed-up on a heating pad in order to maintain body temperature at 36.5 °C. Electrocardiography (ECG) monitorization was initiated using electrodes placed on the extremities following the induction of general anesthesia. A blood sample was obtained at minute 0 through an intravenous catheter of 24 G from the tail vein.
A tracheotomy was performed with the rat in supine position using an 18 G intravenous catheter and mechanical ventilation was initiated with a respiratory rate of 80/minute, tidal volume of 10 ml/kg, and FiO 2 of 0.5 (Ventilator Inspira Asv, Harvard Apparatus, Massachusetts, USA, model number: 0691-001, serial number: B-09035) ( Fig. 1) . A polyethylene catheter (PE-50) was placed in the right femoral artery by dissection under a microscope for blood gas sampling, blood pressure measurement, and heart rate monitorization. (BIOPAC Systems, Inc., Santa Barbara, California: model number: MP30B-CE; serial number: 310B2397) ( Fig. 2 ). For hemodynamic support, lactated Ringer solution was administered through the tail vein.
Techniques described by Pomper and Wauters were used in the experimental surgical procedure (9, 10) . Rats were placed in the prone position and a burr hole was drilled under the microscope in the right front parietal area of the scalp for a Fogarty catheter (3F, 0.20 ml) to be inserted through it ( Fig. 3 ). Cortical activity monitorization was performed during the study period by EEG monitorization using two gold plated electrodes (BIOPAC Systems, Inc., Santa Barbara, California: model number: MP30B-CE; serial number: 310B2397) ( Fig. 4 ). The preparation period took approximately 50-60 minutes for each rat in all groups.
Control group
Following the preparation period, the Fogarty catheter, which was previously placed, was kept uninfl ated until the end of the study. Blood samples were obtained at minutes 150 and 240 through the femoral artery.
Elevated ICP group
Subsequent to the preparation period, ICP was increased using the Fogarty catheter starting at minute 60. A blood sample was drawn through the femoral artery and the balloon of the Fogarty catheter was infl ated completely at minute 150 and BD developed. Rats were sacrifi ced at minute 240 after blood sampling had been performed through the femoral artery.
Brain death group
Subsequent to the preparation period, ICP was increased using the Fogarty catheter starting at minute 60. BD developed in 10-15 minutes. Blood samples were obtained at minutes 150 and 240 through the femoral artery.
The diagnosis of BD was based on the absence of spontaneous respiration and detection of an isoelectric EEG ( Fig. 5 ). Rats were separated from the ventilator for 30 seconds and the absence of spontaneous respiration was confi rmed. Supportive fi ndings such as maximal dilation of pupils and absence of pedal refl exes were also observed. Six rats were excluded from the study; two of them because the preparation period could not be completed in the predetermined time, one because an arterial dislocation occurred. Two rats in which a desired mean arterial tension could not be maintained by fl uid infusions and a rat that developed sudden cardiac arrest were also excluded from the study.
Blood samples were transferred to Eppendorf tubes and stored at -80 °C. Decreased cobalt binding capacity was measured using a rapid calorimetric analysis method which was used previously by Bar-Or et al. Results were expressed as absorbance units (5, (11) (12) (13) . Blood malondialdehyde (MDA) levels were measured using thiobarbituric acid reactive substance (TBARS) method developed by Yagi (11, 14) .
Statistical analysis
For statistical analysis, SPSS v.17 (SPSS Inc., Chicago, IL, USA) was used. IMA and MDA values measured in each group were calculated as mean and standard deviation. Comparison of the values between the groups was performed using the Mann-Whitney U-test and in-group comparisons were performed using the Friedman test. p < 0.05 was accepted as statistically signifi cant.
Results
No difference was found in hemodynamic fi ndings between the groups (Tab. 1).
At minute 0, IMA levels were similar in all three groups. The increase in the IMA levels at minutes 150 and 240 were not signifi cant compared to the basal levels in the control group. The IMA levels were signifi cantly higher at minutes 150 and 240 compared to the basal levels in ICPG (p < 0.05). The IMA levels at minutes 150 and 240 were also signifi cantly higher in ICPG compared to CG (p < 0.05). In the BD group, IMA levels were signifi cantly higher at minute 240 compared to basal levels and those at minute 150. However, basal level of IMA, and those at minutes 150 and 240 of BD group were similar to those in other groups (Tab. 2).
Basal MDA levels were similar in all three groups. No signifi cant difference was found at minutes 150 and 240 in MDA levels in the control group when basal levels were compared.
MDA levels at minutes 150 and 240 were signifi cantly higher in ICPG and BDG groups compared to basal values and control group (p < 0.05). MDA levels were similar in groups ICP and BD (Tab. 3).
Discussion
Brain death in adults develops secondary to anoxic brain damage, traumatic brain damage, subarachnoid bleeding, and ischemic stroke in general. In traumatic brain injury, direct foci of damage or secondary ischemic injuries caused by decreased cerebral perfusion pressure due to brain edema occur. In anoxic brain damage, on the other hand, clinical picture is directly related to the duration of anoxia and impaired oxygenation. In severe anoxic brain damage, ICP markedly increases and may be higher than mean arterial pressure, and when the intracranial blood fl ow is completely obstructed, brain tissue undergoes a gradual liquefaction (15) . Herniation may develop if ICP increases greatly. BD models have been used in various animal studies previously (3, 9, 10, 16) . ICP was increased by a balloon catheter in this study and brain death was performed by creating herniation.
Various pathophysiological cascades such as active enzymes (caspases and metalloproteinases), microcirculation disorders, mitochondrial dysfunction, excessive glial activation, activation of infl ammatory reactions, impaired antioxidant compensation mechanisms, and production of free oxygen radicals develop following head trauma and cerebral ischemia may occur as a result. Progressive intracranial hypertension causing total brain infarct or brain death was created in an experimental study and an attempt was made to determine the threshold level to detect ischemia using various monitorization techniques. In that study, cerebral perfusion pressure was reported to be immediately decreased while ICP increased and brain tissue oxygen levels less than a determined level were reported to be critically important for ischemia (2) . In the current study, ischemia in cerebral tissue in increased ICP was biochemically demonstrated by increased IMA levels.
IMA is a new and sensitive biomarker of ischemia and oxidative stress. It develops by a change in the cobalt binding capacity of albumin in conditions such as free radical production, hypoxia, acidosis, and ischemia and reperfusion (5, 8, 12, 13, 17, 18) . It is measured by an indirect test-the albumin cobalt binding (ACB) test (5, 12, 18) . The present study used the ACB test and the results were given as absorbance units (ABSU). The values of IMA higher than 0.400 ABSU were accepted as low cobalt binding, thus demonstrating ischemia (19) . IMA levels were initially higher (mean levels between 494-519 ABSU) in this present study.
IMA, as approved by US Food and Drug Administration, has been demonstrated in some studies to increase in some pathologies such as myocardial ischemia, mesentery ischemia, pulmonary embolus, cerebrovascular event, end stage renal failure, and tumor (7, 13, (20) (21) (22) (23) . Amino-terminal sequence of human serum albumin is human specifi c (8) . IMA in rats, although suggested not to be equal to the human counterpart, has been reported to be useful in various studies (24, 25) . In previous rat models, IMA was reported not to be signifi cant in acute mesentery ischemia, but it has been suggested that it could be used in ovarian torsion and renal ischemic damage as a non-selective biomarker (26-28). IMA has been demonstrated to be increased in cerebral ischemia (18) . However, to our best knowledge, IMA has not been used in increased ICP and BD.
IMA markedly increases in the early phase of cerebrovascular events (< 3 hours) and can be used in the diagnosis (5, 7, 13) . The IMA increase in cerebrovascular events is dependent on time, and the levels differ according to the type of the cerebrovascular event (5, 13, 29) . IMA levels increase 6-10 minutes after myocardial ischemia in acute coronary syndrome, reach the peak levels at 6 hours, and then decrease to the baseline level at 12-24 hours. The trend for IMA levels in the progress of stroke is also similar to myocardial ischemia. (5, 13, 18, 30) . Gunduz et al demonstrated that IMA levels increased time-dependently in mesenteric ischemia. Therefore, IMA measurement at the second and sixth hours is accepted to be adequate (17) . In this present study, IMA levels demonstrated a time-dependent increase in ICP and BD groups. The IMA increase in the early period in ICPG was detected to be statistically signifi cant; however, the increase in IMA levels in the BD group was not statistically signifi cant as there was no intracranial pressure increase or it was present for only a short time.
Abboud et al, in their study demonstrated that IMA levels refl ected the degree of ischemia in cerebrovascular events (29) . Similarly, in the present study, IMA levels increased with increased ICP levels and/or progressed to BD.
In one study in which stroke, intracerebral bleeding, subarachnoid bleeding, and control groups were compared, IMA levels were 0.280, 0.259, 0.243, and 0.172 ABSU, respectively. As a result, IMA levels signifi cantly increased in all three groups compared to the control group, and it was reported that IMA could be used in the diagnosis of cerebrovascular events. In addition, IMA elevation in cerebral infarct was reported to be signifi cantly increased compared to subarachnoid bleeding. Low levels of IMA in patients with subarachnoid bleeding have been explained by relatively lesser cerebral parenchymal ischemia (13) . In the present study, the reason for insignifi cance of the increase in IMA level in BD group compared to the CG and ICP groups was attributed to the complete obstruction of blood fl ow in BD.
MDA is formed by polyunsaturated fatty acid peroxidation and its level increases following oxidative stress. MDA is a good indicator of free radical production. Turut et al demonstrated that MDA levels increased as a marker of oxidative stress in a pulmonary contusion model (31) . In another study, IMA and MDA activities were tested in a rat testicular torsion model. IMA levels signifi cantly increased while no signifi cant differences were present in the MDA levels (11) . The present study attempted to confi rm IMA levels with MDA levels in increased ICP and BD models. An association of IMA with different groups was also detected in MDA levels.
Conclusion
Monitorization of the level of ischemia is important in increased ICP. The progress to BD can be diagnosed earlier when this process is closely monitored. Although there is no single test to be used in the evaluation of progression to BD, IMA can be used in the early diagnosis of ischemic processes progressing to increased ICP and BD. 
